Abstract
Sera from individual MRL/lpr and MRL/++ mice, which develop an autoimmune disease similar to human systemic lupus erythematosus (SLE), were screened over a period of approximately 30 wk for the presence of anti-RNA polymerase I and anti-ssDNA antibodies. Even though onset of the disease is delayed in MRL/++ as compared to MRL/lpr mice, anti- ssDNA antibodies were present in comparable concentrations in the sera of all mice by the age of 6 wk. As observed in sera of human SLE patients, anti-RNA polymerase I antibodies were detected in the sera of all MRL mice. However, unlike the anti-ssDNA antibodies, anti-RNA polymerase I antibodies were detected much later in MRL/++ mice (mean age, 22.8 wk) as compared to MRL/lpr mice (mean age, 9.6 wk). The presence of anti-RNA polymerase I antibodies in sera of MRL mice was thus a much better indicator of disease status than the presence of anti-ssDNA antibodies. The appearance and increase in anti-RNA polymerase I antibodies in the sera of MRL/++ mice correlated (R2 = 0.964) with a precipitous decrease in anti-ssDNA antibodies, starting at about 20 wk of age. These results suggest a possible relationship between the RNA polymerase I and DNA autoimmune reactions.
Full Text
The Full Text of this article is available as a PDF (734.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Andrews B. S., Eisenberg R. A., Theofilopoulos A. N., Izui S., Wilson C. B., McConahey P. J., Murphy E. D., Roths J. B., Dixon F. J. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med. 1978 Nov 1;148(5):1198–1215. doi: 10.1084/jem.148.5.1198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eisenberg R. A., Tan E. M., Dixon F. J. Presence of anti-Sm reactivity in autoimmune mouse strains. J Exp Med. 1978 Feb 1;147(2):582–587. doi: 10.1084/jem.147.2.582. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hasselbacher P., LeRoy E. C. Serum DNA binding activity in healthy subjects and in rheumatic disease. Arthritis Rheum. 1974 Jan-Feb;17(1):63–71. doi: 10.1002/art.1780170110. [DOI] [PubMed] [Google Scholar]
- Howie J. B., Helyer B. J. The immunology and pathology of NZB mice. Adv Immunol. 1968;9:215–266. doi: 10.1016/s0065-2776(08)60444-7. [DOI] [PubMed] [Google Scholar]
- McCoubrey-Hoyer A., Okarma T. B., Holman H. R. Partial purification and characterization of plasma DNA and its relation to disease activity in systemic lupus erythematosus. Am J Med. 1984 Jul;77(1):23–34. doi: 10.1016/0002-9343(84)90431-5. [DOI] [PubMed] [Google Scholar]
- Rose K. M., Stetler D. A., Jacob S. T. Protein kinase activity of RNA polymerase I purified from a rat hepatoma: probable function of Mr 42,000 and 24,600 polypeptides. Proc Natl Acad Sci U S A. 1981 May;78(5):2833–2837. doi: 10.1073/pnas.78.5.2833. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stetler D. A., Jacob S. T. Phosphorylation of RNA polymerase I augments its interaction with autoantibodies of systemic lupus erythematosus patients. J Biol Chem. 1984 Nov 25;259(22):13629–13632. [PubMed] [Google Scholar]
- Stetler D. A., Rose K. M., Wenger M. E., Berlin C. M., Jacob S. T. Anti-protein kinase NII antibodies in rheumatic autoimmune diseases. J Biol Chem. 1984 Feb 25;259(4):2077–2079. [PubMed] [Google Scholar]
- Stetler D. A., Rose K. M., Wenger M. E., Berlin C. M., Jacob S. T. Antibodies to distinct polypeptides of RNA polymerase I in sera from patients with rheumatic autoimmune disease. Proc Natl Acad Sci U S A. 1982 Dec;79(23):7499–7503. doi: 10.1073/pnas.79.23.7499. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tan E. M. Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol. 1982;33:167–240. doi: 10.1016/s0065-2776(08)60836-6. [DOI] [PubMed] [Google Scholar]
- YACHNIN S. Non-antigenicity of synthetic polyribonucleotides and apurinic acid. Nature. 1962 Sep 29;195:1319–1319. doi: 10.1038/1951319a0. [DOI] [PubMed] [Google Scholar]